Clinical performance of the Sofia™ Influenza A+B FIA in adult patients with influenza-like illness.
The Sofia™ Influenza A+B FIA demonstrated 74.0% sensitivity and 95.4% specificity for influenza A in patients with influenza-like illness in 2012-2013 season. It yielded higher sensitivity than SD Bioline Influenza Ag A/B/A(H1N1/2009) (54.1%) for influenza A (P<0.01). The Sofia™ Influenza A+B FIA might be useful for rapid diagnosis of influenza.